logo
Select company
Select metric
$ -301.19MConsolidated Income
VS
Market
4
Sector
6
Industry
7
History
55
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

SAGE

Company Name

SAGE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SAGE THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SAGE - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -301.19M
3/31/2025$ -354.4M
12/31/2024$ -400.67M
9/30/2024$ -337.59M
6/30/2024$ -445.67M
3/31/2024$ -503.14M
12/31/2023$ -541.49M
9/30/2023$ -655.93M
6/30/2023$ -591.62M
3/31/2023$ -557.56M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SAGE THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -537.48M.
  • Over the past 5 years, SAGE THERAPEUTICS INC's average Cons. Inc. has been $ -258.21M.
  • The median Cons. Inc. for SAGE THERAPEUTICS INC during this period was $ -471.04M
  • SAGE THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ 666.15M.
  • The lowest Cons. Inc. recorded by SAGE THERAPEUTICS INC in the same timeframe $ -655.93M

SAGE THERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
KURA : KURA ONCOLOGY INC $ -197.17MTBPH : THERAVANCE BIOPHARMA INC $ 13.03MNKTR : NEKTAR THERAPEUTICS $ -122.27MZVRA : ZEVRA THERAPEUTICS INC $ 2.64MLXRX : LEXICON PHARMACEUTICALS INC $ -120.62MADCT : ADC THERAPEUTICS SA $ -169.94MYMAB : Y-MABS THERAPEUTICS INC $ -22.22MGOSS : GOSSAMER BIO INC $ -138.74MEYPT : EYEPOINT PHARMACEUTICALS INC $ -175.38MAUTL : AUTOLUS THERAPEUTICS PLC $ -227.78M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

SAGE - Consolidated Income, Last 5 years

$ -655.93M

Minimum

Sep 30, 2023

$ 666.15M

Maximum

Jun 30, 2021

$ -258.21M

Average

$ -471.04M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.05M with a standard deviation of $ 116.48M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.05M
median$ -2.09M
std$ 116.48M